Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:GT
NasdaqGS:GTAuto Components

Assessing Goodyear (GT) Valuation After New Lunar Tire Role In NASA Artemis Missions

Goodyear Tire & Rubber (GT) has moved back into the spotlight after revealing it will supply specialized lunar tires for Lunar Outpost’s Pegasus Lunar Terrain Vehicle, which is part of NASA’s Artemis missions that are planned to begin supporting astronauts in 2028. See our latest analysis for Goodyear Tire & Rubber. Despite the Artemis contract drawing fresh attention, Goodyear’s recent trading tells a different story. The stock’s 30-day share price return is down 12.22% and its 1-year total...
NYSE:SR
NYSE:SRGas Utilities

A Look At Spire (SR) Valuation After Earnings Reset And Long Term Capital Plan Update

Spire (SR) is back in focus after its latest second quarter update, where adjusted earnings came in slightly below estimates, revenue declined year over year, and management reset 2026 guidance alongside a new long term capital plan. See our latest analysis for Spire. Following the earnings reset and long term capital plan, Spire’s recent share price has been choppy, with the stock down over the past quarter but supported by a 1 year total shareholder return of 16.13% and a 5 year total...
NasdaqGS:CTBI
NasdaqGS:CTBIBanks

Should Community Trust Bancorp’s Rising Dividend and 2026 Earnings Outlook Require Action From CTBI Investors?

Community Trust Bancorp recently highlighted its status as a higher-yield payer, with a 3.15% dividend and a record of increasing payouts five times over the past five years. Analysts now expect nearly 12% earnings growth for fiscal 2026, reinforcing the bank’s appeal to income-focused investors who prioritize consistent dividends. With this backdrop of rising dividends, we’ll examine how the earnings growth outlook shapes Community Trust Bancorp’s broader investment narrative. The latest...
NasdaqGS:BSY
NasdaqGS:BSYSoftware

A Look At Bentley Systems (BSY) Valuation After Q1 2026 Growth And Capital Structure Moves

Bentley Systems (BSY) drew fresh investor attention after reporting Q1 2026 results that included 14.5% year-over-year revenue growth, higher subscription and ARR figures, and a new US$550 million term loan alongside repayment of convertible notes. See our latest analysis for Bentley Systems. Despite the solid Q1 update and focus on AI driven workflows, the share price at US$32.93 reflects pressure, with the 90 day share price return down 15.5% and the 1 year total shareholder return down...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

Is CoStar Group (CSGP) Attractive After A 57% Twelve Month Share Price Decline?

If you are wondering whether CoStar Group at around US$33.89 is starting to look like value or still overpriced, the key is to understand what the current share price actually reflects. The stock is roughly flat over the last 7 days at up 0.1% and up 3.4% over the last 30 days, but the longer term picture is much weaker with the share price down 48.4% year to date and down 57.1% over the last 12 months. These declines sit against a backdrop of ongoing attention on CoStar Group's role in real...
TSE:6701
TSE:6701IT

Assessing NEC (TSE:6701) Valuation After Cloud Calling Launch With KDDI And Intermedia

NEC (TSE:6701) is back in focus after the launch of Cloud Calling for UNIVERGE BLUE with KDDI and Intermedia, a nationwide cloud voice service targeting customers who are shifting away from legacy PBX systems. See our latest analysis for NEC. Despite recent headlines around Cloud Calling and NEC's AI recognition at the Newsweek AI Impact Awards, momentum in the share price has been mixed, with a 3.7% 7 day share price return alongside a year to date share price decline of 21.7%. The 5 year...
NasdaqGS:KTOS
NasdaqGS:KTOSAerospace & Defense

Kratos Defense (KTOS) Is Down 7.8% After Jefferies Highlights US$14 Billion Opportunity Pipeline - What's Changed

In recent days, Kratos Defense & Security Solutions reported first-quarter 2026 results that exceeded estimates, raised its full-year 2026 revenue outlook to US$1.70–US$1.76 billion, and highlighted a sharply larger backlog supported by new defense contracts across missiles, drones, and advanced communications. Jefferies’ upgrade to a Buy rating, citing a US$14.00 billion opportunity pipeline and momentum in programs like Prometheus, hypersonics, and Valkyrie, underscores how far-reaching...
TASE:ESLT
TASE:ESLTAerospace & Defense

Elbit Systems (TASE:ESLT) Valuation Check After New US$1.8b Defense Contracts And Earnings Growth

Elbit Systems (TASE:ESLT) is in focus after securing a US$1.4b military modernization contract with a European customer and a US$350m main battle tank upgrade deal, alongside reporting year over year growth in quarterly sales and net income. See our latest analysis for Elbit Systems. The recent contract wins and first quarter earnings update appear to have kept buying interest intact, with a 30.34% year to date share price return and a very large 5 year total shareholder return of 498.14%...
NasdaqGS:ARQT
NasdaqGS:ARQTBiotechs

Assessing Arcutis Biotherapeutics (ARQT) Valuation After New Genital Psoriasis Clinical Guidance Publication

Arcutis Biotherapeutics (ARQT) is back in focus after supporting a new American Journal of Clinical Dermatology manuscript that provides practical guidance on diagnosing and managing genital psoriasis across age groups, highlighting the company’s role in clinician education. See our latest analysis for Arcutis Biotherapeutics. Despite attention on the new genital psoriasis guidance and recent restricted stock unit grants, Arcutis Biotherapeutics’ share price, at US$21.23, has fallen sharply...
NYSE:SVV
NYSE:SVVMultiline Retail

A Look At Savers Value Village (SVV) Valuation After Its Recent Debt Refinancing News

Why Savers Value Village’s latest debt move matters for shareholders Savers Value Village (SVV) amended its credit agreement, cutting applicable rates on existing term loans to 2.50% for Term SOFR Loans and 1.50% for Base Rate Loans. This change directly affects interest costs. See our latest analysis for Savers Value Village. At a latest share price of US$8.99, Savers Value Village’s 1 month share price return of 11.5% contrasts with a year to date share price decline of 4.9% and a 1 year...
AIM:FEVR
AIM:FEVRBeverage

Fevertree Drinks And 2 Other UK Stocks That May Be Priced Below Their Estimated Value

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China and a sluggish global economic recovery. Amidst these broader market pressures, investors often seek stocks that may be undervalued—those trading below their estimated intrinsic value—offering potential opportunities for growth when the market stabilizes.
AIM:RFX
AIM:RFXConsumer Finance

Ramsdens Holdings And 2 Other UK Penny Stocks To Watch

The London markets have been under pressure recently, with the FTSE 100 and FTSE 250 indices slipping due to weak trade data from China, highlighting ongoing global economic challenges. Despite these broader market concerns, investors may find opportunities in penny stocks—smaller or newer companies that can offer unique value propositions. Although the term "penny stocks" might seem outdated, these investments remain relevant for those seeking potential growth and stability within a...
LSE:CARD
LSE:CARDSpecialty Retail

3 UK Dividend Stocks Yielding Up To 7.5%

As the UK markets navigate challenges posed by weak trade data from China, with the FTSE 100 index recently closing lower, investors are closely monitoring how global economic shifts impact their portfolios. In such uncertain times, dividend stocks can offer a measure of stability and income potential, making them an appealing option for those looking to balance risk and reward in their investment strategies.
SWX:NOVN
SWX:NOVNPharmaceuticals

Assessing Novartis (SWX:NOVN) Valuation After Positive Late Stage Results For Cosentyx And Vanrafia

Novartis (SWX:NOVN) is back in focus after releasing late stage trial results for Cosentyx in polymyalgia rheumatica and Vanrafia in IgA nephropathy, with both programs showing statistically significant efficacy and supportive safety data. See our latest analysis for Novartis. These late stage results for Cosentyx, Vanrafia, Scemblix and Pluvicto arrive as Novartis trades at CHF117.98, with a 1 month share price return of 4.08% and a 1 year total shareholder return of 25.23%. This suggests...
NasdaqGM:EMAT
NasdaqGM:EMATMetals and Mining

Assessing Evolution Metals & Technologies (EMAT) Valuation After Recent Share Price Weakness

Why Evolution Metals & Technologies stock is on investors’ radar Evolution Metals & Technologies (EMAT) has drawn attention after a recent pullback, with the stock down about 30% over the past month and roughly 19% over the past 3 months. With a market value near US$4.0b, revenue of US$1.879m and a net loss of about US$1.0b, the company’s focus on critical materials and advanced manufacturing comes amid ongoing share price pressure. See our latest analysis for Evolution Metals &...
NasdaqGS:QFIN
NasdaqGS:QFINConsumer Finance

Qfin Holdings (QFIN) Is Down 14.1% After Soft Q1 Results And Cautious Q2 Outlook - Has The Bull Case Changed?

Qfin Holdings, Inc. recently reported first-quarter 2026 results showing revenue of CNY 3,909.33 million and net income of CNY 883.32 million, alongside second-quarter net income guidance of RMB 830–910 million. The company also announced that board member Mr. Dan Zhao resigned for personal reasons on June 3, 2026, leaving an eight-person board with six independent directors overseeing its AI-driven credit-tech operations. We’ll now examine how Qfin’s weaker first-quarter earnings and...
SEHK:6990
SEHK:6990Biotechs

A Look At Sichuan Kelun-Biotech Biopharmaceutical’s (SEHK:6990) Valuation After Positive 2026 ASCO Lung Cancer Data

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) drew fresh attention after the 2026 ASCO Annual Meeting, where it reported positive Phase III sac-TMT plus pembrolizumab data and pivotal Phase II lunbotinib results in non small cell lung cancer. See our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical. The recent ASCO data drops landed against a mixed trading backdrop, with the share price at HK$393.4 after a 1-day share price return of 0.82%. However, the 7-day share price...
LSE:GEN
LSE:GENBuilding

European Undervalued Small Caps With Insider Buying

European markets have recently experienced a lack of direction, with key indices like the STOXX Europe 600 Index showing slight declines amid geopolitical tensions and economic contraction in the eurozone. In this environment, small-cap stocks can present intriguing opportunities for investors seeking value, particularly when insider buying suggests confidence in a company's potential despite broader market uncertainties.
XTRA:RHM
XTRA:RHMAerospace & Defense

European Value Opportunities Priced Below Intrinsic Estimates In June 2026

As European markets navigate a period of uncertainty, influenced by geopolitical developments and economic contractions, investors are increasingly focused on identifying stocks that may be undervalued relative to their intrinsic value. In such an environment, finding companies with strong fundamentals and potential for growth can offer compelling opportunities for those seeking value in the market.
OM:HTRO
OM:HTROElectrical

European Insider Growth Leaders For June 2026

As European markets grapple with mixed signals, including a recent contraction in the eurozone economy and fluctuating retail sales, investors are increasingly focused on identifying resilient growth opportunities. In such an environment, companies with high insider ownership often stand out as promising contenders due to the alignment of interests between management and shareholders, suggesting potential stability and commitment to long-term growth.
DB:M0LY
DB:M0LYMetals and Mining

Greenland Resources And 2 Other European Penny Stocks To Consider

European markets have recently shown a mixed performance, with the pan-European STOXX Europe 600 Index experiencing a slight decline amid geopolitical uncertainties and economic challenges. Despite these market fluctuations, there remains an opportunity for investors to explore smaller or newer companies, often referred to as penny stocks. While the term "penny stock" might seem outdated, it still represents a sector where companies with strong financials can offer substantial value and...
OM:FIRE
OM:FIREElectronic

Top European Dividend Stocks To Watch In June 2026

As European markets navigate a period of uncertainty, marked by mixed economic signals and geopolitical developments, investors are increasingly focused on defensive strategies to protect their portfolios. In such an environment, dividend stocks can offer a reliable income stream and potential stability, making them an attractive option for those looking to weather market volatility.